Where Science and Policy Meet

Two top 20 lists—from scientists to policy makers and vice versa—aim to bridge gaps in understanding between these groups.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, BUDDAWIGGIThe divide between science and policy is so obvious that a group of scientists writing in Nature last month (November 20) generated a 20-item long list of advice to use when interpreting scientific claims. Chris Tyler, the director of the U.K.’s Parliamentary Office of Science and Technology, has now responded with a list of the top 20 things scientists should know about policy-making, published today (December 2) in The Guardian.

“The immediate priority is to improve policy makers’ understanding of the imperfect nature of science,” William Sutherland and David Spiegelhalter of the University of Cambridge in the U.K. and Mark Burgman of the University of Melbourne in Australia, wrote in Nature. “Politicians are smart, strategic people, they just aren’t sufficiently cautious of scientific advice,” Burgman told The Guardian. “They are either a little intimidated by it, or they ignore it.” The authors’ list of tips for interpreting science included reminders that “correlation does not imply causation,” and that “extrapolating beyond the data is risky.”

“The authors . . . have produced a list that picks up on many of the challenges that scientists report when engaging with policy makers, and it does so in a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies